OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
October 28, 2022
The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.
October 25, 2022
October 01, 2022
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
September 15, 2022
Document integrity is critical in the provision of raw materials for cell and gene therapy manufacturing.
For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.
August 31, 2022
Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.
August 10, 2022
The clinical trial research environment has evolved because of specific solutions designed to overcome uncertainty.
July 13, 2022
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.
July 02, 2022
Finding specific solutions to overcome uncertainty has led to the evolution of a new clinical trial research environment.